Author(s): Fleming CA, Craven DE, Thornton D, Tumilty S, Nunes D, Fleming CA, Craven DE, Thornton D, Tumilty S, Nunes D
Abstract Share this page
Abstract One hundred eighty human immunodeficiency virus (HIV)- and hepatitis C virus (HCV)-coinfected patients were prospectively evaluated for suitability for interferon and ribavirin therapy. Of the 149 patients with chronic HCV infection who completed the evaluation, 44 (30\%) were eligible for treatment and 105 (70\%) were ineligible, with the main barriers being missed clinic visits, active psychiatric illness, active drug or alcohol use, decompensated liver disease, or medical illness.
This article was published in Clin Infect Dis
and referenced in Journal of AIDS & Clinical Research